Company
Sage Therapeutics
Sage Therapeutics has 5 drugs tracked on RxWires: 2 post-market, 1 in Phase 2/3, 1 in Phase 2, 1 in Phase 1.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| Brexanolone | Post-Market | Postpartum Depression |
| Brexanolone Injection [Zulresso] | Post-Market | Post-Traumatic Stress Disorder |
| SAGE-324 | Phase 2/3 | Essential Tremor |
| SAGE-547 | Phase 2 | Essential Tremor |
| Ketamine | Phase 1 | Healthy |
Latest
No recent events.
Follow Sage Therapeutics on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.